InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Enliven Therapeutics, Inc.

ELVN Clue Score23
United States Fiscal year ends December CIK 0001672619 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
46,776
$45.00
$2.10M
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
787,024
$45.38
$35.72M
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
1,477
$45.00
$66.47K
Orbimed Advisors LLC
22 Jun 2026
10% owner
Sell indirect
24,846
$45.38
$1.13M
Orbimed Advisors LLC
15 Jun 2026
10% owner
Sell indirect
272,322
$45.02
$12.26M
Orbimed Advisors LLC
15 Jun 2026
10% owner
Sell indirect
9,086
$45.02
$409.05K
Benjamin Hohl
6 Mar 2026
Chief Financial Officer
Sell
10,000
$29.58
$295.84K
Anish Patel
7 Feb 2025
Chief Operating Officer
Sell indirect
6,667
$21.93
$146.21K
Orbimed Advisors LLC
16 May 2024
Director
Sell indirect
1,000,000
$22.14
$22.14M
Orbimed Advisors LLC
16 May 2024
Director
Sell indirect
33,300
$22.14
$737.26K
Rishi Gupta
16 May 2024
Director
Sell indirect
1,000,000
$22.14
$22.14M
Rishi Gupta
16 May 2024
Director
Sell indirect
33,300
$22.14
$737.26K
Showing 250 of 414 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 327
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 32
Sales on a Rule 10b5-1 plan 150
Sales straight out of an exercise 150
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 45,234,647
Sales filed before the plan box existed 44
History held since 16 Mar 2020